Myasthenia gravis accompanied by alopecia areata: Clinical and immunogenetic aspects

European Journal of Neurology

Volumn 12, Issue 7, 2005, Pages 566-570

  Suzuki, Shigeaki ^a   Shimoda, M ^a   Kawamura, M ^a   Sato, H ^a   Nogawa, S ^a   Tanaka, K ^a   Suzuki, N ^a   Kuwana, M ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alopecia areata; HLA class II; Myasthenia gravis; Thymoma

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CHILD; CLINICAL FEATURE; FEMALE; GENOTYPE; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; MYOCARDITIS; MYOSITIS; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; THYMECTOMY; THYMOMA;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGENETICS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREVALENCE; RETROSPECTIVE STUDIES; THYMECTOMY; THYMOMA;

EID: 21844439527     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2005.01002.x     Document Type: Article

References (15)

1. Drachman DB (1994). Myasthenia gravis. N Engl J Med 330:1797-1810.
2. Evoli A, Minisci C, DiSchino C et al. (2002). Thymoma in patients with MG. Characteristics and long-term outcome. Neurology 59:1844-1850.
3. Inoko H, Ota M (1993). PCR-RFLP. In: Hui KM, Bidwell J. eds. Handbook of HLA Typing Techniques. Boca Raton, FL: CRC Press, pp. 9-70.
4. Kanda F, Jinnai K, Baba H, Shundou F, Tujita T (1986). Myasthenia gravis with alopecia universalis and Hashimoto's disease: a case report. Neurol Med (Tokyo) 25:556 - 558.
5. Kubota A, Komiyama A, Hasegawa O (1997). Myasthenia gravis and alopecia areata. Neurology 48:774 - 775.
6. Masaoka A, Monden Y, Nakahara K, Tanioka T (1981). Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485-2492.
7. McDonagh AJG, Tazi-Ahnini R (2002). Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 27:405-409.
8. Müller-Hermclink HK and Marx A (2000). Thymoma. Curr Opin Oncol 12:426-433.
9. Odom RB, James WD, Berger TG (2000). Andrew's Diseases of the Skin, 9th edn. Philadelphia, PA. W.B. Saunders Company.
10. Randall VA (2001). Is alopecia areata an autoimmune disease? Lancet 358:1922-1923.
11. Rosai J, Sobin LH (1999). Histological typing of tumors of the thymus. International Histologic Classification of Tumors. 2nd edn. New York, Springer.
12. Sempowski GD, Thomasch JR, Gooding ME et al. (2001). Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. J Immunol 166:2808-2817.
13. Suzuki S, Kuwana M, Yasuoka H, Tanaka K, Fukuuchi Y, Kawakami Y (2001). Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis. J Neurol Sci 189:59-64.
14. Suzuki S, Nogawa S, Tanaka K, Koto A, Fukuuchi Y, Kuwana M (2003). Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectomy. Clin Neurol Neurosurg 106:16-18.
15. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Jaretzki A III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000). Myasthenia gravis. Recommendations for clinical research standards. Neurology 55:16-23.